Pros and cons for statins use and risk of Parkinson's disease: An updated perspective

• Main Authors: Hayder M. Al‐kuraishy (Author), Ali I. Al‐Gareeb (Author), Athanasios Alexiou (Author), Marios Papadakis (Author), Abdulrahman A. Alsayegh (Author), Najlaa Hamed Almohmadi (Author), Hebatallah M. Saad (Author), Gaber El‐Saber Batiha (Author)
• Format: Book
• Published: Wiley, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Parkinson's disease (PD) is the second most frequent neurodegenerative brain disease (NBD) after Alzheimer's disease (AD). Statins are the most common lipid‐lowering agents used in the management of dyslipidemia and the prevention of primary and secondary cardiovascular diseases (...